Evidence for a role for transglutaminase in Huntington's disease and the potential therapeutic implications

Becher, 1998, Intranuclear neuronal inclusions in Huntington's disease and DRPLA: correlation between the density of inclusions and IT15 CAG triplet repeat length, Neurobiol. Dis., 4, 387, 10.1006/nbdi.1998.0168 Chen, 2000, Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease, Nat. Med., 6, 797, 10.1038/80538 Cooper, 1997, Polyglutamine domains are substrates of tissue translutaminase: does transglutaminase play a role in expanded CAG/polyQ neurodegenerative diseases?, J. Neurochem., 69, 431, 10.1046/j.1471-4159.1997.69010431.x Davies, 1997, Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation, Cell, 90, 537, 10.1016/S0092-8674(00)80513-9 DiFiglia, 1997, Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain, Science, 277, 1990, 10.1126/science.277.5334.1990 Ferrante, 2000, Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease, J. Neurosci., 20, 4389, 10.1523/JNEUROSCI.20-12-04389.2000 Folk, 1980, Transglutaminases, Annu. Rev. Biochem., 49, 517, 10.1146/annurev.bi.49.070180.002505 Green, 1993, Human genetic diseases due to codon reiteration: relationship to an evolutionary mechanism, Cell, 74, 955, 10.1016/0092-8674(93)90718-6 Huang, 1998, Amyloid formation by mutant hutingtin: threshold, progressivity and recruitment of polyglutamine proteins, Somatic Cell Mol. Genetics, 24, 217, 10.1023/B:SCAM.0000007124.19463.e5 Igarashi, 1998, Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch, Nat. Genetics, 18, 111, 10.1038/ng0298-111 Kahlem, 1996, Peptides containing glutamine repeats are substrates for transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system, Proc. Natl. Acad. Sci. USA, 93, 14580, 10.1073/pnas.93.25.14580 Kahlem, 1998, Transglutaminase action imitates Huntington's disease: selective polymerization of huntingtin containing expanded polyglutamine, Mol. Cell, 1, 595, 10.1016/S1097-2765(00)80059-3 Karpuj, 2000, Cystamine, a competitor for transglutaminase slows the progression of Huntington's disease in a transgenic mouse model without altering formation of nuclear inclusions, Soc. Neurosci. Abstr., 26, 480 Karpuj, 1999, Transglutaminase aggregates Huntingtin into non-amyloidogenic polymers and its enzymatic activity is increased in Huntington's disease brain nuclei, Proc. Natl. Acad. Sci. USA, 96, 7388, 10.1073/pnas.96.13.7388 Lesort, 1998, Distinct nuclear localization and activity of tissue transglutaminase, J. Biol. Chem., 273, 11991, 10.1074/jbc.273.20.11991 Lesort, 1999, Tissue transglutaminase is increased in Huntington's disease brain, J. Neurochem., 73, 2018 Lorand, 1979, Specificity of guinea pig liver transglutaminase for amine substrates, Biochemistry, 18, 1756, 10.1021/bi00576a019 Lorand, 1984, Transglutaminases, Mol. Cell. Biochem., 58, 25, 10.1007/BF00240602 Lorand, 1998, DRPLA aggregation and transglutaminase revisited (letter), Nat. Genetics, 20, 231, 10.1038/3033 Lorand, 1996, Neurodegenerative diseases and transglutaminase, Proc. Natl. Acad. Sci. USA, 93, 14310, 10.1073/pnas.93.25.14310 McGowan, 2000, Amyloid-like inclusions in Huntington's disease, Neuroscience, 100, 677, 10.1016/S0306-4522(00)00391-2 Ona, 1999, Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease, Nature, 399, 263, 10.1038/20446 Orr, 2000, Reversing neurodegeneration: a promise unfolds, Cell, 101, 1, 10.1016/S0092-8674(00)80617-0 Paulson, 1997, Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3, Neuron, 19, 333, 10.1016/S0896-6273(00)80943-5 Perutz, 1999, Glutamine repeats and neurodegenerative diseases: molecular aspects, Trends Biochem. Sci., 24, 58, 10.1016/S0968-0004(98)01350-4 Prusiner, 1983, Scrapie prions aggregate to form amyloid-like birefrigent rods, Cell, 35, 349, 10.1016/0092-8674(83)90168-X Saudou, 1998, Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions, Cell, 95, 55, 10.1016/S0092-8674(00)81782-1 Sisodia, 1998, Nuclear inclusions in glutamine repeat disorders: are they pernicious, coincidental or beneficial?, Cell, 95, 1, 10.1016/S0092-8674(00)81743-2 Scherzinger, 1997, Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo, Cell, 90, 549, 10.1016/S0092-8674(00)80514-0 Yamamoto, 2000, Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease, Cell, 101, 57, 10.1016/S0092-8674(00)80623-6 Zainelli, 2000, Transglutaminase catalyzed cross-links in intranuclear inclusions, Soc. Neurosci. Abstr., 26, 1297